• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Is glycemia control in Canadians with diabetes individualized? A cross-sectional observational study.加拿大糖尿病患者的血糖控制是否因人而异?一项横断面观察性研究。
BMJ Open Diabetes Res Care. 2017 Jun 8;5(1):e000316. doi: 10.1136/bmjdrc-2016-000316. eCollection 2017.
2
High Quality of Diabetes Care Based Upon Individualised Treatment Goals - A Cross Sectional Study in 4784 Patients in Germany.基于个体化治疗目标的高质量糖尿病护理——德国4784例患者的横断面研究
Exp Clin Endocrinol Diabetes. 2016 May;124(5):294-9. doi: 10.1055/s-0035-1569380. Epub 2016 Jan 29.
3
Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from the DIMORA study.使用磺酰脲类或米格列醇的老年患者血糖控制越严格,ADL 躯体依赖丧失越多:来自 DIMORA 研究的结果。
Metabolism. 2015 Nov;64(11):1500-6. doi: 10.1016/j.metabol.2015.07.018. Epub 2015 Jul 29.
4
Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain.在西班牙,使初级保健的2型糖尿病患者达到个体化血糖目标。
BMC Endocr Disord. 2016 Feb 17;16:10. doi: 10.1186/s12902-016-0090-1.
5
Provider beliefs about diabetes treatment have little impact on glycemic control of their patients with diabetes.医务人员对于糖尿病治疗的看法对其患者的血糖控制几乎没有影响。
BMJ Open Diabetes Res Care. 2015 Feb 24;3(1):e000062. doi: 10.1136/bmjdrc-2014-000062. eCollection 2015.
6
Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.在口服降糖药无法实现可接受血糖控制的2型糖尿病患者中使用优泌乐25混合胰岛素:一项III期随机平行研究的结果
Rom J Intern Med. 2003;41(2):153-62.
7
A Retrospective Time Trend Study Of Diabetes Overtreatment In Geriatric Patients.老年患者糖尿病过度治疗的回顾性时间趋势研究
Diabetes Metab Syndr Obes. 2019 Oct 4;12:2023-2032. doi: 10.2147/DMSO.S221179. eCollection 2019.
8
Barriers to the Prevention and Treatment of Geriatric Diabetes.老年糖尿病防治的障碍
Fed Pract. 2015 Oct;32(Suppl 11):16S-20S.

引用本文的文献

1
Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis.伊朗 2 型糖尿病患者的个体化血糖控制:多中心数据分析。
Iran J Med Sci. 2023 May;48(3):286-291. doi: 10.30476/ijms.2022.92805.2409.
2
The Influence of Age, Sex, and Socioeconomic Status on Glycemic Control Among People With Type 1 and Type 2 Diabetes in Canada: Patient-Led Longitudinal Retrospective Cross-sectional Study With Multiple Time Points of Measurement.年龄、性别和社会经济地位对加拿大1型和2型糖尿病患者血糖控制的影响:多时间点测量的患者主导纵向回顾性横断面研究
JMIR Diabetes. 2023 Apr 27;8:e35682. doi: 10.2196/35682.
3
Sensor-Based Technology: Bringing Value to People with Diabetes and the Healthcare System in an Evolving World.基于传感器的技术:在不断发展的世界中为糖尿病患者和医疗保健系统创造价值。
Clinicoecon Outcomes Res. 2022 Feb 10;14:75-90. doi: 10.2147/CEOR.S346736. eCollection 2022.
4
Trends in HbA thresholds for initiation of hypoglycemic agents: Impact of changed recommendations for older and frail patients.HbA 起始低血糖药物治疗阈值的趋势:对老年和虚弱患者推荐改变的影响。
Pharmacoepidemiol Drug Saf. 2021 Jan;30(1):37-44. doi: 10.1002/pds.5129. Epub 2020 Sep 21.
5
Improving care for elderly patients living with polypharmacy: protocol for a pragmatic cluster randomized trial in community-based primary care practices in Canada.提高同时服用多种药物的老年患者的护理水平:在加拿大社区基层医疗实践中开展实用型整群随机试验的方案。
Implement Sci. 2019 Jun 6;14(1):55. doi: 10.1186/s13012-019-0904-4.

本文引用的文献

1
Preventing Unnecessary Costs of Drug-Induced Hypoglycemia in Older Adults with Type 2 Diabetes in the United States and Canada.预防美国和加拿大2型糖尿病老年患者药物性低血糖的不必要费用。
PLoS One. 2016 Sep 20;11(9):e0162951. doi: 10.1371/journal.pone.0162951. eCollection 2016.
2
Representativeness of patients and providers in the Canadian Primary Care Sentinel Surveillance Network: a cross-sectional study.加拿大初级保健哨点监测网络中患者和医疗服务提供者的代表性:一项横断面研究。
CMAJ Open. 2016 Jan 25;4(1):E28-32. doi: 10.9778/cmajo.20140128. eCollection 2016 Jan-Mar.
3
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.利拉鲁肽与2型糖尿病患者的心血管结局
N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.
4
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.恩格列净:在 2 型糖尿病中的心血管结局和死亡率。
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
5
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.基于最新证据的2型糖尿病成年患者心血管疾病预防最新进展:美国心脏协会和美国糖尿病协会的科学声明
Diabetes Care. 2015 Sep;38(9):1777-803. doi: 10.2337/dci15-0012. Epub 2015 Aug 5.
6
Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes.2 型糖尿病患者的血糖控制和心血管结局随访。
N Engl J Med. 2015 Jun 4;372(23):2197-206. doi: 10.1056/NEJMoa1414266.
7
Multiple chronic conditions in type 2 diabetes mellitus: prevalence and consequences.2型糖尿病中的多种慢性疾病:患病率及后果
Am J Manag Care. 2015 Jan 1;21(1):e23-34.
8
Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.老年糖尿病患者强化血糖控制可能存在过度治疗。
JAMA Intern Med. 2015 Mar;175(3):356-62. doi: 10.1001/jamainternmed.2014.7345.
9
Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.强化血糖控制对缺血性心脏病的影响:来自随机对照的ACCORD试验数据分析
Lancet. 2014 Nov 29;384(9958):1936-41. doi: 10.1016/S0140-6736(14)60611-5. Epub 2014 Jul 31.
10
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.《流行病学观察研究报告的强化(STROBE)声明:观察研究报告指南》。
Int J Surg. 2014 Dec;12(12):1495-9. doi: 10.1016/j.ijsu.2014.07.013. Epub 2014 Jul 18.

加拿大糖尿病患者的血糖控制是否因人而异?一项横断面观察性研究。

Is glycemia control in Canadians with diabetes individualized? A cross-sectional observational study.

作者信息

Coons Michael J, Greiver Michelle, Aliarzadeh Babak, Meaney Christopher, Moineddin Rahim, Williamson Tyler, Queenan John, Yu Catherine H, White David G, Kiran Tara, Kane Jennifer J

机构信息

Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Canada.

Medical Bariatric Program, St. Joseph's Healthcare Hamilton, Hamilton, Canada.

出版信息

BMJ Open Diabetes Res Care. 2017 Jun 8;5(1):e000316. doi: 10.1136/bmjdrc-2016-000316. eCollection 2017.

DOI:10.1136/bmjdrc-2016-000316
PMID:28761645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5530242/
Abstract

OBJECTIVE

Diabetes guidelines recommend individualized glycemic targets: tighter control in younger, healthier patients and consideration of more moderate control in the elderly and those with coexisting illnesses. Our objective was to examine whether glycemic control varied by age and comorbidities in Canadian primary care.

RESEARCH DESIGN AND METHODS

Cross-sectional study using data from the electronic medical records of 537 primary care providers across Canada; 30 416 patients with diabetes, aged 40 or above, with at least one encounter and one hemoglobin A1c (HbA1c) measurement between 1 January 2012 and 31 December 2013. The outcome was the most recent HbA1c, categorized into three levels of control: tight (<7.0% or <53 mmol/mol), moderate (7.0%-8.5%, 53 mmol/mol-69.5 mmol/mol) and uncontrolled (>8.5% or >69.5 mmol/mol). We adjusted for several factors associated with glycemic control including treatment intensity.

RESULTS

Younger patients (aged 40-49) were more likely to have moderate as opposed to tight control than the older patients (aged 80+) (OR 1.28; 95% CI 1.11 to 1.49, p=0.001). The youngest were also more likely to have uncontrolled as opposed to moderately controlled glycemia (OR 3.39; 95% CI 2.75 to 4.17, p<0.0001). Patients with no or only one comorbidity were more likely to have moderate as opposed to tight control than those with three or more comorbidities (OR 1.66;95% CI 1.46 to 1.90, p<0.0001).

CONCLUSIONS

Levels of glycemic control, given age and comorbidities appear to differ from guideline recommendations. Research is needed to understand these discrepancies and develop methods to assist providers in personalizing glycemic targets.

摘要

目的

糖尿病指南推荐个体化血糖目标:在年轻、健康的患者中进行更严格的控制,而对于老年人和患有并存疾病的患者则考虑更适度的控制。我们的目的是研究在加拿大初级保健中血糖控制是否因年龄和合并症而异。

研究设计与方法

采用横断面研究,数据来自加拿大537名初级保健提供者的电子病历;30416例40岁及以上的糖尿病患者,在2012年1月1日至2013年12月31日期间至少有一次就诊和一次糖化血红蛋白(HbA1c)测量。结果指标是最近的HbA1c,分为三个控制水平:严格控制(<7.0%或<53 mmol/mol)、适度控制(7.0%-8.5%,53 mmol/mol-69.5 mmol/mol)和未控制(>8.5%或>69.5 mmol/mol)。我们对与血糖控制相关的几个因素进行了调整,包括治疗强度。

结果

与老年患者(80岁以上)相比,年轻患者(40-49岁)更有可能进行适度控制而非严格控制(比值比1.28;95%置信区间1.11至1.49,p=0.001)。最年轻的患者也更有可能血糖未得到控制而非适度控制(比值比3.39;95%置信区间2.75至4.17,p<0.0001)。与患有三种或更多合并症的患者相比,没有合并症或只有一种合并症的患者更有可能进行适度控制而非严格控制(比值比1.66;95%置信区间1.46至1.90,p<0.0001)。

结论

考虑到年龄和合并症,血糖控制水平似乎与指南建议不同。需要开展研究以了解这些差异,并开发方法来帮助医疗服务提供者实现血糖目标的个性化。